Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Zevra Therapeutics (ZVRA) Shares Repurchased (2021 - 2023)

Zevra Therapeutics' Shares Repurchased history spans 3 years, with the latest figure at $3.4 million for Q1 2023.

  • For Q1 2023, Shares Repurchased fell 27.02% year-over-year to $3.4 million; the TTM value through Dec 2023 reached $3.4 million, down 27.02%, while the annual FY2023 figure was $3.4 million, 27.02% down from the prior year.
  • Shares Repurchased reached $3.4 million in Q1 2023 per ZVRA's latest filing, down from $4.7 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $4.7 million in Q1 2022 to a low of $2.8 million in Q4 2021.
  • Average Shares Repurchased over 3 years is $3.7 million, with a median of $3.4 million recorded in 2023.
  • The largest YoY upside for Shares Repurchased was 27.02% in 2023 against a maximum downside of 27.02% in 2023.
  • A 3-year view of Shares Repurchased shows it stood at $2.8 million in 2021, then soared by 67.84% to $4.7 million in 2022, then decreased by 27.02% to $3.4 million in 2023.
  • Per Business Quant, the three most recent readings for ZVRA's Shares Repurchased are $3.4 million (Q1 2023), $4.7 million (Q1 2022), and $2.8 million (Q4 2021).